Literature DB >> 212788

Cholesterol arachidonate as a prostaglandin precursor in adrenocortical cells.

G V Vahouny, R Chanderbhan, V A Hodges, C R Treadwell.   

Abstract

Rat adrenocortical cells were incubated with labeled arachidonate, and the radioactivity in unesterified fatty acids was reduced by washing with 2% albumin solutions. These cells were then incubated for two hours in the absence and presence of 7.1 x 10(-10)M ACTH. During subsequent incubation of prelabeled cells with ACTH, both the mass and radioactivity of arachidonate in adrenocortical cholesteryl esters was depleted to the same extent (30--32%). The released arachidonate was in part incorporated into phospholipids, and there was also a significant increase in unesterified arachidonic acid. During this period, there was also increased incorporation of arachidonate into labeled prostaglandins. Of this increase, 92% by isotope analysis, and 88% by radioimmunoassay techniques was attributable to prostaglandins of the E pathway. These data demonstrate that prostaglandin E synthesis is specifically increased during ACTH stimulation of rat adrenocortical cells and suggest that a major source of the arachidonate substrate for this synthesis is derived from hormone-dependent hydrolysis of cortical cholesteryl esters.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 212788     DOI: 10.1016/0090-6980(78)90022-9

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  3 in total

Review 1.  How is the level of free arachidonic acid controlled in mammalian cells?

Authors:  R F Irvine
Journal:  Biochem J       Date:  1982-04-15       Impact factor: 3.857

2.  The failure of indomethacin to alter ACTH-induced adrenal hyperaemia or steroidogenesis in the anaesthetized dog.

Authors:  J G Gerber; A S Nies
Journal:  Br J Pharmacol       Date:  1979-10       Impact factor: 8.739

3.  The effect of systemic prednisolone on arachidonic acid, and prostaglandin E2 and F2 alpha levels in human cutaneous inflammation.

Authors:  A Kobza Black; M W Greaves; C N Hensby
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.